BIT:RECPharmaceuticals
Recordati Industria Chimica e Farmaceutica (BIT:REC) Valuation Check After Updated 2026 Revenue Guidance
Recordati Industria Chimica e Farmaceutica (BIT:REC) has updated the market with fresh revenue guidance, projecting €2,730 million to €2,800 million for 2026, while keeping its 2027 net revenue target range unchanged at €3,000 million to €3,200 million.
See our latest analysis for Recordati Industria Chimica e Farmaceutica.
The updated guidance and ongoing share buyback come after a 5.26% 1 month share price return to €48.42. The 1 year total shareholder return of 8.52% contrasts with a...